Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -81.04% is 51% above its 5-year average of -164.68%, near the high end of its 5-year range (-1969.83%–288.10%).
5.93% below its 12-month average of -76.51%.
Reported quarterly profit margin; no daily interpolation. Q1 FY2027 (2026-06-30): -17.96%.
NET PROFIT MARGIN
-81.04%
NET PROFIT MARGIN AVG TTM
-76.51%
NET PROFIT MARGIN AVG 3Y
-167.63%
NET PROFIT MARGIN AVG 5Y
-164.68%
NET PROFIT MARGIN AVG 10Y
-142.04%
NET PROFIT MARGIN AVG 15Y
-192.80%
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-5.93%
CURRENT VS 3Y AVG
+51.66%
CURRENT VS 5Y AVG
+50.79%
CURRENT VS 10Y AVG
+42.95%
CURRENT VS 15Y AVG
+57.97%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 691 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Canopy Growth Corporation
Market Cap
$374.20M
Net Profit Margin
-81.04%
TTM Avg
-76.51%
3Y Avg
-167.63%
5Y Avg
-164.68%
Market Cap
$381.44M
Net Profit Margin
-391.90%
TTM Avg
-78.17%
3Y Avg
-42.66%
5Y Avg
-429.16%
Market Cap
$385.22M
Net Profit Margin
-7.41%
TTM Avg
-13.48%
3Y Avg
-12.88%
5Y Avg
-9.86%
Market Cap
$365.09M
Net Profit Margin
-1091.82%
TTM Avg
-436.37%
3Y Avg
-220.06%
5Y Avg
-1750.93%
Market Cap
$359.46M
Net Profit Margin
-1786.27%
TTM Avg
-1435.22%
3Y Avg
-1851.09%
5Y Avg
-9692.20%
Market Cap
$390.00M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-102.82%
5Y Avg
-175.43%
Market Cap
$356.40M
Net Profit Margin
-5.49%
TTM Avg
-11.37%
3Y Avg
-410.78%
5Y Avg
-2049.25%
Market Cap
$355.31M
Net Profit Margin
-96.89%
TTM Avg
-148.47%
3Y Avg
-151.80%
5Y Avg
-119.69%
Market Cap
$354.94M
Net Profit Margin
0.00%
TTM Avg
-11651.99%
3Y Avg
-6142.69%
5Y Avg
-4693.07%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Canopy Growth Corporation (CGC) | $374.20M | -81.04% | -76.51% | -167.63% | -164.68% |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $381.44M | -391.90% | -78.17% | -42.66% | -429.16% |
| Orthofix Medical Inc. (OFIX)vs › | $385.22M | -7.41% | -13.48% | -12.88% | -9.86% |
| Opus Genetics, Inc. (IRD)vs › | $365.09M | -1091.82% | -436.37% | -220.06% | -1750.93% |
| Ocugen, Inc. (OCGN)vs › | $359.46M | -1786.27% | -1435.22% | -1851.09% | -9692.20% |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $390.00M | 0.00% | 0.00% | -102.82% | -175.43% |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $356.40M | -5.49% | -11.37% | -410.78% | -2049.25% |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $355.31M | -96.89% | -148.47% | -151.80% | -119.69% |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $354.94M | 0.00% | -11651.99% | -6142.69% | -4693.07% |
| Embecta Corp. (EMBC)vs › | $354.25M | 8.59% | 7.90% | 10.47% | 19.48% |
Operating Margin
-32.0%
Net Profit Margin
-81.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -17.96% |
| 2026-03-31 | -220.53% |
| 2025-12-31 | -84.02% |
| 2025-09-30 | -2.46% |
| 2025-06-30 | -57.57% |
| 2025-03-31 | -339.51% |
| 2024-12-31 | -163.05% |
| 2024-09-30 | -203.67% |
| 2024-06-30 | -192.02% |
| 2024-03-31 | -126.86% |
| 2023-12-31 | -276.16% |
| 2023-09-30 | -445.45% |
| 2023-06-30 | -49.99% |
| 2023-03-31 | -965.39% |
| 2022-12-31 | -305.79% |
| 2022-09-30 | -332.23% |
| 2022-06-30 | -1969.83% |
| 2022-03-31 | -514.11% |
| 2021-12-31 | -77.27% |
| 2021-09-30 | -8.42% |
| 2021-06-30 | 288.10% |
| 2021-03-31 | -471.56% |
| 2020-12-31 | -592.93% |
| 2020-09-30 | -23.70% |
| 2020-06-30 | -98.27% |
| 2020-03-31 | 423.38% |
| 2019-12-31 | -73.81% |
| 2019-09-30 | 337.96% |
| 2019-06-30 | -205.42% |
| 2019-03-31 | -356.84% |
| 2018-12-31 | 81.38% |
| 2018-09-30 | -1445.26% |
| 2018-06-30 | -309.76% |
| 2018-03-31 | -269.86% |
| 2017-12-31 | 7.29% |
| 2017-09-30 | -7.62% |
| 2017-06-30 | -37.70% |
| 2017-03-31 | -143.78% |
| 2016-12-31 | 30.68% |
| 2016-09-30 | 63.90% |
| 2016-06-30 | -56.54% |
| 2016-03-31 | -101.59% |
| 2015-12-31 | -95.26% |
| 2015-09-30 | 159.34% |
| 2015-06-30 | 59.16% |
| 2015-03-31 | -173.39% |
| 2014-12-31 | -411.38% |
| 2014-09-30 | -751.81% |
| 2014-06-30 | -614.78% |
| 2014-03-31 | 0.00% |
| 2014-01-31 | -58745.83% |
| 2013-10-31 | -729.09% |
| 2013-07-31 | -3783.37% |
| 2013-04-30 | -509.64% |
| 2013-01-31 | -1192.60% |
| 2012-10-31 | -3840.34% |
| 2012-07-31 | 0.00% |
| 2012-04-30 | -656.30% |
| 2012-01-31 | -758.14% |
| 2011-10-31 | -193.10% |
| 2011-07-31 | -30.23% |
| 2011-04-30 | -625.35% |
| 2011-01-31 | -891.78% |
| 2010-10-31 | -232.56% |
| 2010-07-31 | -25.14% |
| 2010-04-30 | 0.00% |
| 2010-01-31 | 0.00% |
